Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset(EPA) - No Study Results Posted - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset(EPA)

This study is currently recruiting participants.

Study NCT00512239 Information provided by Universitaire de Sherbrooke

First Received: August 6, 2007 No Changes Posted

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	September 2009
Estimated Primary Completion Date:	No date given

Publications:

Boire G, Cossette P, de Brum-Fernandes AJ, Liang P, Niyonsenga T, Zhou ZJ, Carrier N, Daniel C, Menard HA. Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis. Arthritis Res Ther. 2005;7(3):R592-603. Epub 2005 Mar 17.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Guzian MC, Carrier N, Cossette P, de Brum-Fernandes AJ, Liang P, Ménard HA, Boire G. Outcomes in recent-onset inflammatory polyarthritis differ according to initial titers, persistence over time, and specificity of the autoantibodies. Arthritis Care Res (Hoboken). 2010 Nov;62(11):1624-32. Epub 2010 Jul 8.

Back to top of Main Content